Zealand Pharma A/S Banner Image

Zealand Pharma A/S

  • Ticker ZEAL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zealand Pharma A/S Logo Image
  • 201-500 Employees
  • Based in Søborg, Denmark
Zealand Pharma (Nasdaq: ZEAL) is a biotechnology company focused on the discovery, development, and commercialization of next generation peptide-based medicines that change the lives of people living with metabolic and gastrointestinal diseases. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s robustMore pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go®, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics.
4.7 / 5.0 (68)

Zealand Pharma A/S reports have an aggregate usefulness score of 4.7 based on 68 reviews.

Zealand Pharma A/S

Most Recent Annual Report

Zealand Pharma A/S
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Zealand Pharma A/S Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!